Robust Immune Responses for Herpes Zoster Subunit Vaccine

MONDAY, May 21, 2018 -- Recipients of the herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01B Adjuvant System, develop robust immune responses, according to a study published in the June 1 issue...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news